Coarse-grained model leads to collective behavior. by Giovanna De Palo (476510)

“…The peak in susceptibility becomes higher the larger the number of cells, and NN distances decrease accordingly. Profiles in the inset were smoothed with a moving average filter spanning ten points. …”

Supplementary Material for: Real-World Experience with Artificial Intelligence-Based Triage in Transferred Large Vessel Occlusion Stroke Patients by Morey J.R. (10592381)

Effect of Tie2 knockout on the expression of members of the Ang/Tie pathway in organs of <i>Tie2</i> knockout mice. by Peter J. Zwiers (7510744)

Effect Of Adalimumab Treatment On İnflammatory And Hematological Parameters İn Patients With Hidradenitis Suppurativa by Kadir Kaya (19333212)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B by Teerha Piratvisuth (279131)

“…Myalgia was more common in the monotherapy group (19% versus 7%). No decrease in the mean glomerular filtration rate occurred in either treatment group at Week 52.…”

Supplementary Material for: Predictors of early versus delayed neurological deterioration after thrombolysis for ischemic stroke: ENCHANTED study by Han Q. (14236679)

Data from "Earthworms modify plant biomass and nitrogen capture under conditions of soil nutrient heterogeneity and elevated atmospheric CO2 concentrations" by Fernando T. Maestre (99334)

Supplementary Material for: Reduction of Caloric Intake Might Override the Prosteatotic Effects of the <b><i>PNPLA3</i></b> p.I148M and <b><i>TM6SF2</i></b> p.E167K Variants in Pat... by Krawczyk M. (4157323)

Datasheet1_Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life.docx by Nikolay N. Murashkin (15350677)

Image_3_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_4_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_1_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_1_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_4_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_3_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_2_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Image_2_Bacterial RNA Contributes to the Down-Modulation of MHC-II Expression on Monocytes/Macrophages Diminishing CD4+ T Cell Responses.TIF by M. Ayelén Milillo (4325953)

Virtual magnetic intensity map (VMI-map) and generation of individual tracks by pigeons inside this map. by Cordula V. Mora (456425)

“…Note that coloured bands on the map do not represent a step-wise increase in magnetic intensity, but were only used to aid visual comparison of a pigeon's tracks during a session. …”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”